118 related articles for article (PubMed ID: 18248801)
41. Comparative drug release studies of two cationic drugs from pH-responsive nanogels.
Tan JP; Goh CH; Tam KC
Eur J Pharm Sci; 2007 Dec; 32(4-5):340-8. PubMed ID: 17950583
[TBL] [Abstract][Full Text] [Related]
42. Controlled release of insulin from pH/temperature-sensitive injectable pentablock copolymer hydrogel.
Huynh DP; Im GJ; Chae SY; Lee KC; Lee DS
J Control Release; 2009 Jul; 137(1):20-4. PubMed ID: 19285530
[TBL] [Abstract][Full Text] [Related]
43. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery.
Doadrio AL; Sousa EM; Doadrio JC; Pérez Pariente J; Izquierdo-Barba I; Vallet-Regí M
J Control Release; 2004 May; 97(1):125-32. PubMed ID: 15147810
[TBL] [Abstract][Full Text] [Related]
44. Differential scanning calorimetry study on drug release from an inulin-based hydrogel and its interaction with a biomembrane model: pH and loading effect.
Castelli F; Sarpietro MG; Micieli D; Ottimo S; Pitarresi G; Tripodo G; Carlisi B; Giammona G
Eur J Pharm Sci; 2008 Sep; 35(1-2):76-85. PubMed ID: 18619534
[TBL] [Abstract][Full Text] [Related]
45. A new biocompatible nanoparticle delivery system for the release of fibrinolytic drugs.
Piras AM; Chiellini F; Fiumi C; Bartoli C; Chiellini E; Fiorentino B; Farina C
Int J Pharm; 2008 Jun; 357(1-2):260-71. PubMed ID: 18313868
[TBL] [Abstract][Full Text] [Related]
46. Effect of acceptor phosphate buffer pH value on indomethacin release.
Vercimáková M; Vitková Z; Simunková V
Pharmazie; 2007 Feb; 62(2):156. PubMed ID: 17341039
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
Yang Y; Hua C; Dong CM
Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
[TBL] [Abstract][Full Text] [Related]
48. Selected Rofams as a micellar solubilizers for diclofenac and naproxen in the environment of the standard vehicle for eye drops.
Nachajski MJ; Zgoda MM
Polim Med; 2005; 35(3):39-47. PubMed ID: 16440896
[TBL] [Abstract][Full Text] [Related]
49. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.
Puglia C; Blasi P; Rizza L; Schoubben A; Bonina F; Rossi C; Ricci M
Int J Pharm; 2008 Jun; 357(1-2):295-304. PubMed ID: 18343059
[TBL] [Abstract][Full Text] [Related]
50. Quaternized chitosan (QCS)/poly (aspartic acid) nanoparticles as a protein drug-delivery system.
Wang Tw; Xu Q; Wu Y; Zeng Aj; Li M; Gao H
Carbohydr Res; 2009 May; 344(7):908-14. PubMed ID: 19303066
[TBL] [Abstract][Full Text] [Related]
51. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
[TBL] [Abstract][Full Text] [Related]
52. Cytokine adsorption/release on uniform magnetic nanoparticles for localized drug delivery.
Mejías R; Costo R; Roca AG; Arias CF; Veintemillas-Verdaguer S; González-Carreño T; del Puerto Morales M; Serna CJ; Mañes S; Barber DF
J Control Release; 2008 Sep; 130(2):168-74. PubMed ID: 18588929
[TBL] [Abstract][Full Text] [Related]
53. pH- and photo-switched release of guest molecules from mesoporous silica supports.
Aznar E; Marcos MD; Martínez-Máñez R; Sancenón F; Soto J; Amorós P; Guillem C
J Am Chem Soc; 2009 May; 131(19):6833-43. PubMed ID: 19402643
[TBL] [Abstract][Full Text] [Related]
54. Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization.
Mehanna MM; Elmaradny HA; Samaha MW
Drug Dev Ind Pharm; 2009 May; 35(5):583-93. PubMed ID: 19031311
[TBL] [Abstract][Full Text] [Related]
55. PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: cyclosporin A as an example.
Velluto D; Demurtas D; Hubbell JA
Mol Pharm; 2008; 5(4):632-42. PubMed ID: 18547055
[TBL] [Abstract][Full Text] [Related]
56. Thermosensitive micelles based on folate-conjugated poly(N-vinylcaprolactam)-block-poly(ethylene glycol) for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Steeber DA; Gong S
Macromol Biosci; 2009 Aug; 9(8):744-53. PubMed ID: 19370751
[TBL] [Abstract][Full Text] [Related]
57. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
Yang P; Quan Z; Li C; Kang X; Lian H; Lin J
Biomaterials; 2008 Nov; 29(32):4341-7. PubMed ID: 18715638
[TBL] [Abstract][Full Text] [Related]
58. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin.
Sun H; Guo B; Cheng R; Meng F; Liu H; Zhong Z
Biomaterials; 2009 Oct; 30(31):6358-66. PubMed ID: 19666191
[TBL] [Abstract][Full Text] [Related]
59. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers.
Bae Y; Kataoka K
Adv Drug Deliv Rev; 2009 Aug; 61(10):768-84. PubMed ID: 19422866
[TBL] [Abstract][Full Text] [Related]
60. New insight into modified release pellets - Internal structure and drug release mechanism.
Ensslin S; Moll KP; Paulus K; Mäder K
J Control Release; 2008 Jun; 128(2):149-56. PubMed ID: 18433911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
